decision analysis prof. carl thompson [email protected]

27
Decision Analysis Prof. Carl Thompson [email protected]

Upload: arnold-atkinson

Post on 16-Dec-2015

220 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Decision Analysis

Prof. Carl [email protected]

Page 2: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

What is decision analysis?

• Based on a normative theory of decision making: subjective expected utility theory (SEUT)

• Assumes– Decision process logical and rational– Works on basis that rational decision

maker will choose the option that maximises their utility (the desirability or value attached to a decision outcome)

Page 3: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

What is decision analysis?

“Decision analysis is a systematic, explicit, quantitative way of making decisions in health care that can … lead to both enhanced communication about clinical controversies and better decisions.” (Hunink, Glasziou et al, 2001, p.3.)

Page 4: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

What is decision analysis?

• Assists in understanding of a decision task

• Divides decision task into its components

• Use of decision trees as a way of structuring the decision task– Uses evidence in the form of probabilities –

so can examine the risks associated with different options

– Examines the utility or cost associated with each option

• Suggests the most appropriate decision option for that particular situation

Page 5: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Stages in a decision analysis

• Structure the problem as a decision tree - identifying choices, information (what is and is not known) and preferences

• assess numerically the probability (chances) of every choice branch

• assess numerically the utility (preferences) of every outcome state

• identify option which maximises expected utility

• carry out a sensitivity analysis to explore effect of varying judgements

• ‘toss -up’ if two options have same EU (Dowie, 1993)

Page 6: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Structure the problemElizabeth Harding: 78 year old lady with

atrial fibrillation (AF), currently not on any anticoagulation therapy.

The decision problem: AF is associated with an increased risk of thromboembolic stroke. Treatment with anticoagulation therapy can reduce the risk of stroke, however there is an associated risk of bleeding. If prescribed Warfarin, then regular monitoring of INR is needed. If prescribed aspirin, there is a risk of gastrointestinal side effects.

Page 7: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Structure the problem

• Illustrated using a decision tree– structure of tree dictates values

needed and outcomes considered.– should be structured with the aid of

an expert in the field– need for compromise between

simplifying problem too much and including enough detail for it to be relevant to the problem (Doubilet & McNeil, 1988

Page 8: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

The structure of a decision tree

• Square node– Decision node– Represents choice

between actions• Circle node

– Chance node– Represents

uncertainty– Potential

outcomes of each decision

Page 9: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Consequences or Chances

• Consequences of each decision option and chance of event occurring– Short term and long term

• Need best available evidence– Includes risks and benefits of

interventions– Natural history of disease– Accuracy and interpretation of

diagnostic test information

Page 10: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Clinical problem

• Alternatives for Mrs Harding include:– No treatment– Prescription of Warfarin– Prescription of Aspirin

• Consequences or chances include:– Stroke (either through thromboemolism or

bleed)• Which may or may not lead to severe disability

– Treatment side effects

Page 11: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk
Page 12: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Chances

• Use probability or chance of events occurring

• For each ‘branch’ in the decision tree, values have to add up to 1 or 100%

• Specific measures of the uncertainty associated with the decision– Highlights the risks associated with each

decision option• Probabilities should come from good

quality research evidence

Page 13: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk
Page 14: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Assessing Utility/Preference

• When there is more than one type of consequence – valuation important

• Trade-offs between benefits and potential harms of consequences

• Need clarification of the values involved• Choice of intervention will often depend

on the values of the decision maker• When considering values, need to

consider whether individual or societal

Page 15: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Measuring utility/values

• Need a strategy that weighs harms and benefits explicitly in accordance with values of population/individual

• Utility measures– Are a measure of the desirability of all the

possible outcomes in the decision tree– Provide a numerical value attached to

beliefs and feelings– Are measured on a numerical scale where 0

= worst possible outcome and 100 = best possible outcome

Page 16: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Utility measures

• Quality Adjusted Life Years (QALY) commonly used for population utility measures – 1 year in perfect health = 1 QALY. Health states measured against this (e.g. 2 years in health rated as 0.5 of perfect health = 1 QALY) Considers quantity and quality of life.

• Rating scales• Standard Gamble• Time trade off

Page 17: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Calculating expected utility

• Values are placed in decision tree by appropriate outcomes

• Expected value for each branch calculated by multiplying utility with probability

• Expected values for each branch of tree added together to give EU for each decision option

• Depending on nature of values, option with highest/lowest value is the option that should be taken

Page 18: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk
Page 19: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk
Page 20: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk
Page 21: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Sensitivity Analysis

• Necessary if numbers used in analysis are uncertain

• Allows you to examine the effect different values will have on outcome

• Known as sensitivity analysis– vary uncertain variables over range that is

considered plausible– Can calculate effect of uncertainty on

decision

Page 22: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Sensitivity Analysis

Sensitivity Analysis on Utility associated with having side effects of

treatment

0.945

0.95

0.955

0.96

0.965

0.97

0.975

0.98

0.985

0.99

0.7

Utility associated with having side effects of treatment

Exp

ecte

d V

alu

e

No treatment

Warfarin

Aspirin

• If the value or utility of having side effects associated with the treatment (with no stroke) is less than 0.84, then no treatment is the preferred option. If the utility is above 0.84, then Warfarin is the preferred treatment

Page 23: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Sensitivity analysis

• In this situation the decision is ‘preference sensitive’ with regard to how the individual feels about having side effects associated with anticoagulation therapy.

• Decisions can also be ‘probability sensitive’

Page 24: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

1 way sensitivity analysis HIV prophylaxis

Page 25: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Benefits

• Makes all assumptions in a decision explicit

• Allows examination of the decision process used

• Way of integrating evidence into the decision process

• Often insight gained during process more important than the actual numbers used

• Can be used for individual decisions, population level decisions and for cost-effectiveness analysis

Page 26: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

Limitations

• Probability estimates– often data sets needed to estimate

probability don’t exist– Subjective probability estimates are open to

bias: overconfidence & heuristics• Utility measures

– often ask individuals to rate a state of health that they have no experience of

– Different techniques will result in different numbers

– Subject to framing effects

Page 27: Decision Analysis Prof. Carl Thompson cat4@york.ac.uk

References• Sources of Evidence

– Prodigy Guidance – Atrial Fibrillation www.prodigy.nhs.uk/guidance.asp?gt=Atrial%20fibrillation– Protheroe J, Fahey T, Montgomery AA, Peters TJ (2000) The

impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 320: 1380-4

– Hankey GJ, Sudlow CLM, Dunbabin DW. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. The Cochrane Database of Systematic Reviews 1999, Issue 4. Art. No.: CD001246. DOI: 10.1002/14651858.CD001246.

• Further Reading– Llewelyn H, Hopkins A (1993) Analysing how we reach

clinical decisions. Royal College of Physicians of London.